Life Sciences
In the Amsterdam Metropolitan Area, Life Sciences is a continually strengthening sector. From the cutting-edge facilities of Science Park Amsterdam to groundbreaking research and a busy schedule of international conferences, investment in Amsterdam's Life Sciences is paying off.
Amsterdam welcomes Alvimedica
Alvimedica, a Turkish provider of cardiology products, has announced that the company will use its new Amsterdam base to coordinate their global brand and marketing activities. Read more... »European hematologists gather in Amsterdam
Amsterdam is set to host the 17th Congress of the European Hematology Association (EHA) from 14 to 17 June 2012. More than 9,000 participants are expected to visit the city. Read more... »Development in Medical Business Park Amsterdam begins
The official launch of two new business incubators on 17 February 2012 marked the start of the development of the Medical Business Park in Amsterdam. Read more... »Science Park Amsterdam expands
Science Park Amsterdam has announced the development of a new business complex intended to provide office and laboratory space for the Life Sciences sector. Read more... »Games for Health conference in Amsterdam
The Games for Health Conference was held in Amsterdam, bringing together researchers, game developers and medical professionals. Read more... »Amsterdam hospital has world first with rheumatism research
The Academic Medical Centre in Amsterdam is to conduct groundbreaking research in which a microchip is inserted under the skin of patients suffering from rheumatoid arthritis. Read more... »Fonterra opens R&D centre in Amsterdam
Dairy giant Fonterra has opened its research and development centre in Amsterdam, concluding its move from Germany to the Netherlands. Read more... »Agendia receives EU Funding for development
Agendia, a Dutch firm specialising in molecular cancer diagnostics will receive 1.27 million euros for its research in this area. Read more... »Agendia intention to list on Amsterdam Stock Exchange
Agendia, a Dutch firm specialising in molecular cancer diagnostics, has announced its intention to list on the New York Stock Exchange (NYSE) Euronext in Amsterdam. Read more... »Eisai opens up shop in the Netherlands
Eisai, a Japanese pharmaceutical company, announced the establishment of its sales and marketing operation in the Netherlands. Read more... »
